The presence of carbapenemase-producing Enterobacteriaceae (CPE) in healthcare institutions represents a considerable threat to public health. In 2015 the Department of Health and Human Services in Victoria established CPE guidelines. These guidelines require clinical diagnostic laboratories to submit suspected CPE isolates to the state public health laboratory (MDU PHL) for molecular confirmatory testing and determination of clonality to identify potential transmission.
Designing laboratory procedures and processes to meet the guidelines has required the input of numerous personnel: laboratory scientists, clinical staff, epidemiologists, bioinformaticians, and IT personnel. The workflow design process is ongoing and currently incorporates phenotypic screening, real-time multiplex PCR for selected genes and whole genome sequencing to determine resistance alleles and relatedness of CPE isolates. Implementation of a reference laboratory service for CPE incorporating genomics has facilitated focused infection control interventions for Victoria, Australia. This presentation will discuss some of the challenges and successes to date.